We are heading for #WODC 2024 in Barcelona!
If the rapid removal of ADA/nAbs by decoys (w/o systemic immunosuppression!) is of interest to you, we would be happy to talk and exchange. Schedule a one-on-one meeting with Ablevia CEO, Oskar Smrzka, and Sr. Scientist - BD, Patrice Douillard to learn about our antibody removal technology and explore exciting partnering opportunities with us!
Just one week to go! Stop by the Ablevia biotech pod (Start-up zone S7) to discover our latest breakthroughs.